Pentavalent-specific T cells Therapy (University Of Patras General Hospital)

N/A

Report date: 2022/11/27 23:58:28

Base Information

Drug NamePentavalent-specific T cells Therapy (University Of Patras General Hospital)
Drug Alias NamePentavalent-specific T cells (penta-STs)Pentavalent-specific T cellspenta-STspenta-STs
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsBone marrow transplant rejectionVirus DiseasesOpportunistic Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGreece
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Patras General Hospital
China Registration ClassN/A

Develop Information

Active CompaniesGeorge Papanicolaou HospitalUniversity Of Patras General Hospital
Inactive CompaniesN/A
Active IndicationsBone marrow transplant rejectionVirus DiseasesOpportunistic Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A